Publication:
Interactions in vitro between agents used to treat melioidosis

dc.contributor.authorD. A.B. Danceen_US
dc.contributor.authorV. Wuthiekanunen_US
dc.contributor.authorW. Chaowagulen_US
dc.contributor.authorN. J. Whiteen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherJohn Radcliffe Hospitalen_US
dc.contributor.otherSappasitthiprasong Hospitalen_US
dc.date.accessioned2018-06-14T09:15:04Z
dc.date.available2018-06-14T09:15:04Z
dc.date.issued1989-09-01en_US
dc.description.abstractCombinations of antimicrobial agents are usually recommended for the treatment of melioidosis. In Thailand, the conventional treatment regimen for Pseudomonas pseudomallei infections is a combination of chloramphenicol, doxycycline and cotrimoxazole. We have consistently observed antagonism between these agents during routine disc susceptibility testing. Interactions between these antimicrobials were studied further by a chequerboard microdilution method, using five clinical isolates of P. pseudomallei. Both trimethoprim and sulphamethoxazole antagonised the bacteriostatic activity of chloramphenicol and doxycycline. The combination of trimethoprim and sulphamethoxazole was synergistic, but not bactericidal. Bacteriostatic drugs antagonised the bactericidal activity of ceftazidime, which is undergoing clinical trials in severe melioidosis. These findings may be of therapeutic relevance. © 1989 by The British Society for Antimicrobial Chemotherapy.en_US
dc.identifier.citationJournal of Antimicrobial Chemotherapy. Vol.24, No.3 (1989), 311-316en_US
dc.identifier.doi10.1093/jac/24.3.311en_US
dc.identifier.issn03057453en_US
dc.identifier.other2-s2.0-0024457146en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/15804
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0024457146&origin=inwarden_US
dc.subjectMedicineen_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titleInteractions in vitro between agents used to treat melioidosisen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0024457146&origin=inwarden_US

Files

Collections